Male sexual performance-Male erectile dysfunction. Sexual dysfunction, not caused by organic disorder or disease
Conditions
Interventions
Intervention 1: In the intervention group, N-acetylcysteine ??tablets with a dose of 2400 mg manufactured in Oh Sina Pharmaceutical Company 2 times a day are added to methadone maintenance treatment f
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: The presence of sexual activity (such as intercourse, caressing a partner without having sex, foreplay and masturbation) in the last 4 weeks under MMT treatment More than 8 weeks under methadone maintenance treatment. Consent to participate in the study
Exclusion criteria
Exclusion criteria: People who had a history of erectile dysfunction and used drugs for erection such as diuretics, anticholinergic and antipsychotic drugs, phosphodiesterase 5 inhibitors Patients who have a history of cardiovascular problems based on arteriosclerosis and peripheral vascular diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Determining the effect of methadone treatment along with N-acetylcysteine ??on men's sexual performance compared to methadone treatment. Timepoint: Determining and comparing the level of sexual dysfunction before and 12 weeks after receiving methadone + N-acetylcysteine. Method of measurement: Questionnaires of depression, sexual function, and cognitive function are completed for patients before and 12 weeks after treatment. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMena Dostizadeh
Hamedan University of Medical Sciences
Outcome results
None listed